Navigation Links
delSECUR CORPORATION Announces Agreement to Purchase the Intellectual Property Assets of the Corporation
Date:8/4/2009

SOUTH BURLINGTON, Vt., Aug. 4 /PRNewswire-FirstCall/ -- delSECUR CORPORATION, a Nevada Corporation, (Pink Sheets: DLSC) announced today that its Board of Directors has accepted, subject to the approval of the majority of the shareholders entitled to vote, an agreement to purchase the Intellectual Property Assets of delSECUR CORPORATION. The consideration for such purchase will be in the form of a 49% interest in the shares of common stock of Q Tech Systems, Inc., an Ontario, Canada Corporation.

The primary asset to be acquired by Q Tech is the del-ID technology, a patented device and system of authenticating individuals through biometric means invented by Pierre de Lanauze, the former President & CEO of delSECUR. Q Tech, which also develops and markets technologies to enhance security and identification processes, plans to incorporate the del-ID technology with its proprietary technology. "Q Tech will be immediately focusing on the invention of Pierre de Lanauze's analog technology and believes it can make this combined technology commercially viable and bring it to the marketplace," said Randall McCormick, delSECUR's current CEO.

Mr. McCormick further stated, "We believe this is a great opportunity for the advancement of the del-ID technology and puts our business plan and mission statement immediately into action without further delay.

It is time to bring the del-Id technology to the next level and to test its capabilities. With this new alliance we are much closer to that goal."

delSECUR, a public company (Pink Sheets: DLSC) with its head office in S. Burlington, VT., is a technology development company of a unique authentication process based on abstract images of biological data collected from the fingers of living persons.

For further information contact us at: investorrelations@delsecur.com

This Press Release may contain forward-looking statements. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," and other similar statements. Statements that are not historical facts, including statements relating to anticipated future earnings, margins, and other operating results, future growth, construction plans and anticipated capacities, production schedules and entry into expanded markets are forward-looking statements. Such forward-looking statements, based upon the current beliefs and expectations of our management, are subject to risks and uncertainties, which could cause actual results to differ materially from the forward-looking statements and are subject to the risks normally associated with the completions of a corporate transaction. The information set forth herein should be read in light of such risks. We assume no obligation to update the information contained in this press release, except as required under applicable law.


'/>"/>
SOURCE delSECUR CORPORATION
Copyright©2009 PR Newswire.
All rights reserved

Related biology news :

1. delSECUR CORPORATION Announces Appointment of the Companys President & CEO
2. $29.4 million grant establishes CTSI at NYU in partnership with Health and Hospitals Corporation
3. CEL-SCI Corporation to Launch Aseptic Filling for Stem Cell Produced Therapies and Other Biological Products
4. Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2008 Results
5. Communication Intelligence Corporation Reports Third Quarter 2008 Financial Results
6. Carbon Disclosure Project: Worlds largest corporations seek clarity on climate change regulation
7. L-1 Identity Solutions Completes Acquisition of the ID Systems Business from Digimarc Corporation
8. Communication Intelligence Corporation Reports Second Quarter 2008 Financial Results
9. Corporations can profit from being environmentally friendly
10. Communication Intelligence Corporation Closes $3.6 Million Financing
11. MXI Security and Communication Intelligence Corporation Team up to Deliver the First Green Portable Security Solution for Financial Institutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2016)... 2016 Das DOTM ... Nepal hat ein 44 Millionen ... Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an ... und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale ... teilgenommen, aber Decatur wurde als konformste und ...
(Date:5/24/2016)... May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled technology ... LCD display is the latest premium product recently added to the range of products ... ... ... 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/3/2016)... 3, 2016  Neurotechnology, a provider of high-precision ... Automated Biometric Identification System (ABIS) , a complete ... MegaMatcher ABIS can process multiple complex biometric transactions ... of fingerprint, face or iris biometrics. It leverages ... and MegaMatcher Accelerator , which have been ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... June 23, 2016 , ... UAS LifeSciences, one of ... their brand, UP4™ Probiotics, into Target stores nationwide. The company, which has been ... Target to its list of well-respected retailers. This list includes such fine stores ...
(Date:6/23/2016)... 2016 Houston Methodist Willowbrook Hospital has ... Association to serve as their official health care ... Willowbrook will provide sponsorship support, athletic training services, ... coaches, volunteers, athletes and families. "We ... Association and to bring Houston Methodist quality services ...
(Date:6/23/2016)... FRANCISCO , June 23, 2016   EpiBiome ... has secured $1 million in debt financing from Silicon ... ramp up automation and to advance its drug development ... its new facility. "SVB has been an ... beyond the services a traditional bank would provide," said ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: